/Investor DB

McKesson Ventures — 2020 Investments

5 investments dated 2020 · listed companies and verified rows first · show all

Evidation Healthevidation.comin𝕏Jul 2020 · $45M

Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.

BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US

Christine Lemke(Executive Officer, Director)inDeborah Kilpatrick(Executive Officer, Director)Leslie Oley Wilberforcein

BoardDavid Fleshman(Director)Rowan Chapman(Director)in

Co-investorsAsset Management CompanyB Capital GroupB4 CapitalCross Creek AdvisorsDementia Discovery FundFresco Capital+7 more

Lightshiplightshiprv.comin𝕏Feb 2020 · $20M

Lightship designs and builds the AE.1, an all-electric travel trailer for the RV market.

CleantechDirect to ConsumerHardwareMobility & TransportationBroomfield, US

Tobias Kraus(Executive Officer, Director)Toby Kraus(Co-Founder & Chief Executive Officer)inBenjamin Parker(Founder)inHayley Cashdollar(Chief Operating Officer)inNick Herron(Chief Engineer)inRob Williams(Chief Creative Officer)in

Co-investorsAlumni VenturesClimacticCongruent VenturesHyperguapJetstreamObvious Ventures+5 more

Lightshiplightship.cominFeb 2020 · $20M

Lightship provides clinical trial operations for biopharma companies, CROs, and academic institutions, offering site services, decentralized and hybrid trial models, patient recruitment, and mobile research units.

BiotechDigital HealthHealthtechEl Segundo, US

David MacMurchy(Founder)inMichael Shipton(Chief Business Officer)inDarcy Forman(Chief Operating Officer)inLindsay Van Pelt(Chief Medical Advisor)inBen Parker(Founder)Benjamin Parker(Founder)

Co-investorsHikma VenturesALLEGIS CAPITALAlumni VenturesClimacticCongruent VenturesDefine Ventures+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Koneksa HealthOncology Analytics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.